当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析

安图生物

(603658)

  

流通市值:206.57亿  总市值:206.57亿
流通股本:5.71亿   总股本:5.71亿

安图生物(603658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润8.73亿元,每股收益1.50元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益884554.54万元,未分配利润452273.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1172694.48万元,负债288139.95万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,127,156,171.62,060,307,179.95995,933,663.324,471,202,509.22
营业总成本2,294,860,260.371,506,453,270.45746,443,403.963,307,150,305.92
其他经营收益
营业利润952,196,649.69636,811,439.57303,498,951.951,245,488,947.45
利润总额959,174,314638,845,435.17302,138,440.131,289,056,474.19
净利润872,725,088.32578,036,989.75273,079,722.471,199,233,279.89
每股收益
其他综合收益-84,048.63-8,422.01-12,112106,410.67
综合收益总额872,641,039.69578,028,567.74273,067,610.471,199,339,690.56
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,880,262,392.785,930,679,670.166,462,106,370.666,542,768,991.5
非流动资产:
非流动资产合计5,846,682,436.925,714,704,290.295,505,925,305.885,332,296,952.47
资产总计11,726,944,829.711,645,383,960.4511,968,031,676.5411,875,065,943.97
流动负债:
流动负债合计2,280,644,264.582,531,681,037.532,462,122,219.572,659,547,350.97
非流动负债:
非流动负债合计600,755,206.63562,770,036.38536,052,608.02523,722,740.07
负债合计2,881,399,471.213,094,451,073.912,998,174,827.593,183,270,091.04
所有者权益(或股东权益):
归属于母公司股东权益合计8,746,504,579.18,458,066,259.738,876,936,827.168,616,530,318.04
股东权益合计8,845,545,358.498,550,932,886.548,969,856,848.958,691,795,852.93
负债和股东权益合计11,726,944,829.711,645,383,960.4511,968,031,676.5411,875,065,943.97
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,581,762,531.262,320,053,939.831,210,943,311.025,093,794,765.32
经营活动现金流出小计2,736,340,717.871,909,870,014.481,044,604,852.763,784,512,024.2
经营活动产生的现金流量净额845,421,813.39410,183,925.35166,338,458.261,309,282,741.12
投资活动产生的现金流量:
投资活动现金流入小计4,040,066,091.922,767,973,416.1410,024,513.892,623,053,898.83
投资活动现金流出小计3,801,634,004.42,465,838,886.17391,016,832.233,808,281,321.69
投资活动产生的现金流量净额238,432,087.52302,134,529.97-380,992,318.34-1,185,227,422.86
筹资活动产生的现金流量:
筹资活动现金流入小计1,582,459,788.591,295,522,997.74746,196,189.371,286,955,484.92
筹资活动现金流出小计2,529,002,548.462,008,806,278.48767,303,924.892,445,785,430.42
筹资活动产生的现金流量净额-946,542,759.87-713,283,280.74-21,107,735.52-1,158,829,945.5
汇率变动对现金及现金等价物的影响2,418,501.373,246,257.443,228,949.871,463,670.6
现金及现金等价物净增加额139,729,642.412,281,432.02-232,532,645.73-1,033,310,956.64
期末现金及现金等价物余额591,787,991.22454,339,780.83219,525,703.08452,058,348.81
补充资料:
现金及现金等价物的净增加额-2,281,432.02--1,033,310,956.64
最新报告期:2025-11-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟2.062.402.782025-11-21
中信建投王在存,贺菊颖2.002.132.342025-11-17
兴业证券孙媛媛,黄翰漾1.962.162.512025-11-10
太平洋谭紫媚2.012.302.762025-11-10
光大证券王明瑞,黎一江2.212.583.012025-11-02
TOP↑